Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour

Pigment Cell Research

Volumn 20, Issue 4, 2007, Pages 288-300

  Bondanza, Sergio ^a   Maurelli, Riccardo ^a   Paterna, Patrizia ^a   Migliore, Eleonora ^a   Giacomo, Fabio Di ^a   Primavera, Giovanni ^a   Paionni, Emanuel ^a   Dellambra, Elena ^a   Guerra, Liliana ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cultured keratinocytes; Cultured melanocytes; In vitro reconstituted epidermis; Keratinocyte senescence; Vitiligo

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; PROTEIN P16; PROTEIN P53;

ARTICLE; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; COCULTURE; HUMAN; HUMAN CELL CULTURE; KERATINOCYTE; LIFESPAN; MELANOCYTE; PROTEIN EXPRESSION; REGULATORY MECHANISM; VITILIGO;

ADULT; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; HUMANS; KERATINOCYTES; MALE; MELANOCYTES; STEM CELL FACTOR; VITILIGO;

EID: 34447298067     PISSN: 08935785     EISSN: 16000749     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2007.00385.x     Document Type: Article

References (49)

1. Barrandon, Y. Green, H. (1987). Three clonal types of keratinocytes with different capacities for multiplication. Proc. Natl Acad. Sci. U S A 84, 2302 2306.
2. Bates, S., Phillips, A.C., Clark, P.A., Stott, F., Peters, G., Ludwig, R.L. Vousden, R.L. (1998). P14ARF links the tumour suppressors RB and p53. Nature 395, 124 125.
3. Bessou, S., Gauthier, Y., Surlève-Bazeille, J.E., Pain, C. Taïeb, A. (1997). Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease. Br. J. Dermatol. 137, 890 897.
4. Bhawan, J. Bhutani, L.K. (1983). Keratinocyte damage in vitiligo. J. Cutan. Pathol. 10, 207 212.
5. Bondanza, S., Bellini, M., Roversi, G., Raskovic, D., Maurelli, R., Paionni, E., Paterna, P., Dellambra, E., Larizza, L. Guerra, L. (2007). Piebald trait: implication of kit mutation on in vitro melanocyte survival and on the clinical application of cultured epidermal autografts. J. Invest. Dermatol. 127, 676 686.
6. Chaturvedi, V., Cesnjaj, M., Bacon, P., Panella, J., Choubey, D., Diaz, M.O. Nickoloff, B.J. (2003). Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes. Am. J. Pathol. 162, 161 170.
7. De Luca, M., D'Anna, F., Bondanza, S., Franzi, A.T. Cancedda, R. (1988a). Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. J. Cell. Biol. 107, 1919 1926.
8. De Luca, M., Franzi, A.T., D'Anna, F., Zicca, A., Albanese, E., Bondanza, S. Cancedda, R. (1988b). Coculture of human keratinocytes and melanocytes: differentiated melanocytes are physiologically organized in the basal layer of the cultured epithelium. Eur. J. Cell. Biol. 46, 176 180.
9. Dell'Anna, M.L. Picardo, M. (2006). A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 19, 406 411.
10. Dellambra, E., Golisano, O., Bondanza, S., Siviero, E., Lacal, P., Molinari, M., D'Atri, S. De Luca, M. (2000). Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell. Biol. 149, 1117 1130.
11. Fitzpatrick, T.B. Breathnach, A.S. (1963). The epidermal melanin unit system. Dermatol. Wochenschr. 147, 481 489.
12. Gandarillas, A. (2000). Epidermal differentiation, apoptosis, and senescence: common pathways? Exp. Gerontol. 35, 53 62.
13. Gauthier, Y., Cario Andre, M. Taïeb, A. (2003a). A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 16, 322 332.
14. Gauthier, Y., Cario Andre, M., Lepreux, S., Pain, C. Taïeb, A. (2003b). Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br. J. Dermatol. 148, 95 101.
15. Gottifredi, V., McKinney, K., Poyurovsky, M.V. Prives, C. (2004). Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J. Biol. Chem. 279, 5802 5810.
16. Guerra, L., Capurro, S., Melchi, F., Primavera, G., Bondanza, S., Cancedda, R., Luci, A., De Luca, M. Pellegrini, G. (2000). Treatment of stable vitiligo by TIMED surgery and transplantation of cultured epidermal autografts. Arch. Dermatol. 136, 1380 1389.
17. Guerra, L., Primavera, G., Raskovic, D. et al. (2003). Erbium: YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch. Dermatol. 139, 1303 1310.
18. Guerra, L., Primavera, G., Raskovic, D., Pellegrini, G., Golisano, O. Bondanza, S. et al. (2004). Permanent repigmentation of piebaldism by erbium: YAG laser and autologous cultured epidermis. Br. J. Dermatol. 150, 715 721.
19. Guerra, L., Bondanza, S. Raskovic, D 2007). Transplantation of in vitro cultured epithelial grafts for vitiligo and piebaldism. In Surgical Management of Vitiligo, S. Gupta, M.J. Olsson, A.J. Kanwar J.P. Ortonne, eds (Oxford : Blackwell Publishing Ltd pp. 180 190.
20. Hann, S.K., Park, Y.K., Lee, K.G., Choi, E.H. Im, S. (1992). Epidermal changes in active vitiligo. J. Dermatol. 19, 217 222.
21. Huang, C.L., Nordlund, J.J. Boissy, R. (2002). Vitiligo. A manifestation of apoptosis? Am. J. Clin. Dermatol. 3, 301 308.
22. Kitamura, R., Tsukamoto, K., Harada, K., Shimizu, A., Shimada, S., Kobayashi, T. Imokawa, G. (2004). Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCK/KIT protein interactions and the downstream effector, MITF-M. J. Pathol. 202, 463 475.
23. Le Poole, I.C. Das, P.K. (1997). Microscopic changes in vitiligo. Clin. Dermatol. 15, 863 873.
24. Le Poole, I.C., van den Wijngaard, R.M.J.G.J., Westerhof, W., Dutrieux, R.P. Das, P.K. (1993). Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J. Invest. Dermatol. 100, 816 822.
25. Le Poole, I.C., Van Den Wijngaard, R.M.J.G.J., Westerhof, W. Das, P.K. (1997). Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion. Br. J. Dermatol. 137, 171 178.
26. Lee, A.Y., Youm, Y.H., Kim, N.H., Yang, H. Choi, W.I. (2004). Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis. Br. J. Dermatol. 151, 995 1003.
27. Lee, A.Y., Kim, N.H., Choi, W.I. Youm, Y.H. (2005). Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than in normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J. Invest. Dermatol. 124, 976 983.
28. Maga, G. Hübscher, U. (2003). Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051 3060.
29. Maga, G., Blanca, G., Shevelev, I., Frouin, I., Ramadan, K., Spadari, S., Villani, G. Hubscher, U. (2004). The human DNA polymerase λ interacts with PCNA through a domain important for DNA primer binding and the interaction is inhibited by p21/WAF/CIP1. FASEB 18, 43 45.
30. Maurelli, R., Zambruno, G., Guerra, L., Abruzzese, C., Dimri, G., Gellini, M., Bondanza, S. Dellambra, E. (2006). Inactivation of p16INK4a immortalizes primary human keratinocytes by maintaining cells in the stem cell compartment. FASEB J. 20, 1516 1518.
31. Moellmann, G., Klein-Angerer, S., Scollay, D.A., Nordlund, J.J. Lerner, A.B. (1982). Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J. Invest. Dermatol. 79, 321 330.
32. Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fagiani, M. Fabbri, P. (2003). New insight into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res. 15, 87 92.
33. Munro, J., Stott, F.J., Vousden, K.H., Peters, G. Parkinson, E.K. (1999). Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res. 59, 2516 2521.
34. Okazaki, M., Yoshimura, K., Uchida, G. Harii, K. (2005). Correlation between age and the secretion of melanocyte-stimulating cytokines in cultured keratinocytes and fibroblasts. Br. J. Dermatol. 153 (Suppl. 2 23 29.
35. Ongenae, K., Van Geel, N. Naeyaert, J.M. (2003). Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 16, 90 100.
36. Ortonne, J.P., Bahadoran, P., Fitzpatrick, T.B., Mosher, D.B. Hori, Y 2003). Hypomelanoses and hypermelanoses. In Fitzpatrick's Dermatology in General Medicine, 6th edn, I.M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith S.I. Katz, eds (New York : McGraw-Hill Inc. pp. 839 847.
37. Panuncio, A.L. Vignale, R. (2003). Ultrastructural studies in stable vitiligo. Am. J. Dermatopathol. 25, 16 20.
38. Passeron, T. Ortonne, J.P. (2005). Physiopathology and genetics of vitiligo. J. Autoimmun. 25, S63 S68.
39. Rheinwald, J.G., Hahn, W.C., Ramsey, M.R., Wu, J.Y., Guo, Z., Tsao, H., De Luca, M., Catricalà, C. O'Toole, K.M. (2002). A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22, 5157 5172.
40. Rochat, A., Kobayashi, K. Barrandon, Y. (1994). Location of stem cells of human hair follicles by clonal analysis. Cell 76, 1063 1073.
41. Schallreuter, K.U 2005). Vitiligo, pathogenesis, diagnosis, management. In Autoimmune Diseases of the Skin, M. Hertl, ed New York : Springer Wien pp. 367 384.
42. Schallreuter, K.U., Tobin, D.J. Panske, A. (2002). Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 204, 194 201.
43. Schallreuter, K.U., Behrens-Williams, S., Khaliq, T.P., Picksley, S.M., Peters, E.M.J., Marles, L.K., Westerhof, W., Miehe, B. Fanghanel, J. (2003). Increased epidermal functioning wild-type p53 expression in vitiligo. Exp. Dermatol. 12, 268 277.
44. Shay, J.W. Wright, W.E. (2005). Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26, 867 874.
45. Spritz, R.A. (2006). The genetics of generalized vitiligo and associated autoimmune diseases. J. Dermatol. Sci. 41, 3 10.
46. Taïeb, A. (2000). Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res. 13, 41 47.
47. Tobin, D.J., Swanson, N.N., Pittelkow, M.R., Peters, E.M. Schallreuter, K.U. (2000). Melanocytes are not absent in lesional skin of long duration vitiligo. J. Pathol. 191, 407 416.
48. Van Den Wijngaard, R.M.J.G.J., Aten, J., Scheepmaker, A., Le Poole, I.C., Tigges, A.J., Westerhof, W. Das, P.K. (2000). Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo. Br. J. Dermatol. 143, 573 581.
49. Zhang, X.J., Chen, J.J. Liu, J.B. (2005). The genetic concept of vitiligo. J. Dermatol. Sci. 39, 137 146.